Article

2010 SABCS Interview with Stacy Moulder, MD

Dr. Stacy Moulder reviews her research on PARP inhibitors for hard-to-treat breast cancers.

In this interview, Stacy L. Moulder, MD, assistant professor of breast medical oncology at The University of Texas MD Anderson Cancer Center, talks about her research on PARP inhibitors for hard-to-treat breast cancers, such as triple-negative breast cancer, and the collaborative team that continues this line of research.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.